LiverRx: Liver Support for FIP Cats

LiverRx: An Essential Component of Every FIP Treatment Protocol

FIP places extraordinary demands on the liver — both from the systemic inflammatory cascade triggered by FCoV infection, and from the continuous metabolic burden of processing antiviral therapy over weeks to months of treatment. LiverRx is formulated specifically to address this hepatic stress, and is strongly recommended as a standard component of every FIP treatment protocol, from day one through to the end of treatment.

Active Ingredients and Mechanism of Action

LiverRx contains a clinically supported combination of S-Adenosyl L-Methionine (SAMe), Silybin (derived from Milk Thistle extract), Vitamin E, and Vitamin C. These compounds work synergistically to deliver comprehensive hepatic support:

• Hepatoprotection: SAMe and Silybin reinforce hepatocyte membrane integrity and neutralise free radical damage generated during active inflammation.
• Anti-inflammatory activity: Silybin exerts direct anti-inflammatory effects that are particularly relevant in the context of FCoV-driven hepatic involvement.
• Hepatic regeneration: SAMe supports methylation pathways and glutathione synthesis — both critical to hepatocyte repair and renewal.
• Antioxidant defence: Vitamins E and C act in concert to reduce systemic oxidative stress at the cellular level.

Expected Clinical Outcomes

Cats receiving LiverRx alongside antiviral therapy consistently demonstrate improved clinical progress across several key parameters:

• Earlier return of appetite — A well-supported liver plays a central role in metabolic regulation and appetite signalling, and recovery in this area is often one of the earliest and most noticeable improvements observed.
• Improved weight gain and lean muscle recovery — When nutrient absorption is optimised, the body can effectively direct protein and energy toward muscle rebuilding and systemic recovery.
• Enhanced antiviral efficacy — A healthier liver metabolises and distributes antiviral compounds more efficiently, supporting the overall therapeutic effect of treatment.
• Accelerated clinical recovery — Cats with better hepatic function consistently show faster and more pronounced improvements in condition scores throughout the treatment course.
• Reduced risk of hepatic complications — Proactive liver support from the outset helps mitigate the risk of liver-related setbacks that could compromise or interrupt treatment.

Clinical Recommendation

Given the liver's central role in every aspect of FIP treatment — from drug metabolism to immune recovery — LiverRx is strongly recommended as a standard addition to all FIP protocols, regardless of disease form: wet, dry, or neurological. Supporting liver health from the start is not simply adjunctive care. It is foundational to treatment success.